Age, sex, and smoking are predictors of circulating insulin-like growth factor I and insulin-like growth factor-binding protein 3

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 813-817

  Kaklamani, Virginia G ^a   Linos, Athena ^a   Kaklamani, Evangelia ^a   Markaki, Ioanna ^a   Mantzoros, Christos ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; COFFEE; CONTROLLED STUDY; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; FEMALE; GREECE; HORMONE BLOOD LEVEL; HUMAN; LIFESTYLE; MALE; MALIGNANT NEOPLASTIC DISEASE; NORMAL HUMAN; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING;

EID: 0033022305     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.813     Document Type: Article

References (41)

1. LeRoith D, Clemmons D, Nissley P, et al: NIH conference: Insulin-like growth factors in health and disease. Ann Intern Med 116:854-862, 1992
2. Daughaday WH: The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127:1-4, 1990
3. Tritos N, Mantzoros CS: Recombinant human growth hormone: Old and novel uses. Am J Med 105:44-57, 1998
4. Bach LA, Rechler MM: Insulin-like growth factors and diabetes. Diabetes Metab Rev 8:229-257, 1992
5. Rudman D, Feller AG, Hangraj HS, et al: Effect of human growth hormone in men over 60 years old. N Engl J Med 323:1-6, 1990
6. Hirschberg R, Kopple JD: Effects of growth hormone and IGF-I on renal function. Kidney Int Suppl 27:S20-S26, 1989
7. Mantzoros CS, Tzonou A, Signorello LB, et al: Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 76:1115-1118, 1997
8. Chan J, Stampfer MJ, Giovannucci E, et al: Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 279:563-566, 1998
9. Wolk A, Mantzoros CS, Andersson SO, et al: Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study. J Natl Cancer Inst 90:911-915, 1998
10. Hankinson SE, Willett WC, Colditz GA, et al: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396, 1998
11. Bohlke K, Cramer DW, Trichopoulos D, et al: Insulin like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9:570-573, 1998
12. Goodman-Gruen D, Barrett-Connor E: Epidemiology of insulin-like growth factor-I in elderly men and women: The Rancho Bernardo Study. Am J Epidemiol 145:970-976, 1997
13. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al: Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol 41:351-357, 1994
14. Signorello LB, Tzonou A, Mantzoros CS, et al: Serum steroids in relation to prostate cancer risk in a case-control study (Greece). Cancer Causes Control 8:632-636, 1997
15. Mantzoros CS, Georgiadis EI: Body build and physical activity are important predictors of serum androgen concentrations in young healthy men. Epidemiology 6:432-435, 1995
16. Giovannucci E, Rimm EB, Stampfer MJ, et al: Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6:557-563, 1997
17. Andersson SO, Wolk A, Bergstrom R, et al: Body size and prostate cancer: A 20-year follow-up study among 135,006 Swedish construction workers. J Natl Cancer Inst 89:385-389, 1997
18. Underwood LE, Van Wyk JJ: Normal and aberrant growth, in Wilson JD, Foster DW (eds): Williams Textbook of Endocrinology (ed 8). Philadelphia, PA, Saunders, 1992, pp 1079-1139
19. Bruning PF, Van Doom J, Boufrer JM, et al: Insulin-like growth factor binding protein 3 is decreased in early-stage operable premenopausal breast cancer. Int J Cancer 62:266-270, 1995
20. de Herder WW, van der Lely AJ, Lamberts SWJ: Colorectal cancer screening in acromegaly: Still many unresolved questions. Clin Endocrinol 47:644-646, 1997
21. Jorgensen JO, Vahl N, Hansen TB, et al: Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects. Clin Endocrinol 48:479-486, 1998
22. Copras E, Harman SM, Blackman MR: Human growth hormone and human aging. Endocr Rev 14:20-39, 1993
23. Cohick WS, Clemmons DR: The insulin-like growth factors. Annu Rev Physiol 55:131-153, 1993
24. Tritos N, Mantzoros CS: Clinical Review: Syndromes of severe insulin resistance. J Clin Endocrinol Metab 83:3025-3030, 1998
25. Santolaria F, Gonzales-Gonzales G, Gonzales-Reimers E, et al: Effects of alcohol and liver cirrhosis on the GH-IGF-1 axis. Alcohol Alcohol 30:703-708, 1995
26. Gelato MC, Frost RA: IGFBP3: Functional and structural implications in aging and wasting syndromes. Endocrine 7:81-85, 1997
27. Orme SM, McNally RJQ, Cartwright RA, et al for the United Kingdom Acromegaly Study Group: Mortality and cancer incidence in acromegaly: Retrospective cohort study. J Clin Endocrinol Metab 83:2730-2734, 1998
28. Hsing AW, McLaughlin JK, Chow WH, et al: Risk factors for colorectal cancer in a prospective study among U.S. white men. Int J Cancer 77:549-553, 1998
29. Heineman EF, Zahm SH, McLaughlin JK, et al: Increased risk of colorectal cancer among smokers: Results of a 26-year follow up of US veterans and a review. Int J Cancer 59:728-738, 1994
30. Boyle P: Cancer, cigarette smoking and premature death in Europe: A review including the recommendations of the European Cancer Experts Consensus Meeting, Helsinki, October 1996. Lung Cancer 17:1-60, 1997
31. Doll R, Peto R: Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ 2:1525-1536, 1976
32. Hammond EC: Smoking in relation to mortality and morbidity: Findings in first thirty-four months of follow-up in a prospective study started in 1959. J Natl Cancer Inst 32:1161-1188, 1964
33. Weir JM, Dunn JE Jr: Smoking and mortality: A prospective study. Cancer 25:105-112, 1970
34. Cederlof R, Friberg L, Hrubec Z, et al: The relationship of smoking and some social covariables to mortality and cancer morbidity: A ten year follow-up in a probability sample of 55,000 Swedish subjects age 18 to 69 (2 parts). Stockholm, Sweden: Karolinska Institute, 1975
35. Castersen JM, Pershagen G, Eklund G: Mortality in relation to cigarette and pipe smoking: 16 years' observation of 25,000 Swedish men. J Epidemiol Community Health 41:166-172, 1987
36. Severson RK, Nomura AMY, Grove JS, et al: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49:1857-1860, 1989
37. Palmer JR, Rosenberg L: Cigarette smoking and the risk of breast cancer. Epidemiol Rev 5:145-156, 1993
38. Bennicke K, Conrad C, Sabroe S, et al: Cigarette smoking and breast cancer. BMJ 310:1431-1433, 1995
39. Ishibe N, Hankinson SE, Colditz GA, et al: Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res 58:667-671, 1998
40. Oh Y, Muller HL, Lamson G, et al: Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells: Cell surface binding and growth inhibition. J Biol Chem 268:14964-14971, 1993
41. Trichopoulos D, MacMahon B: Epidemiology: Principles and Methods (ed 2). Boston, MA, Little Brown, 1996